The use of MRI as an outcome measure in clinical trials.

Advances in neurology

Volumn 98, Issue , 2006, Pages 203-226

  Li, David K B ^a   Li, Mary Jane ^a   Traboulsee, Anthony ^a   Zhao, Guojun ^a   Riddehough, Andrew ^a   Paty, Donald ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DISABILITY; DISEASE COURSE; DRUG EFFECT; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RECURRENT DISEASE; REVIEW; STANDARD; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; CLINICAL TRIALS; DISABILITY EVALUATION; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; RECURRENCE; TREATMENT OUTCOME;

EID: 33644843721     PISSN: 00913952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (206)